Seung Seo Lee

Dr. Seung Seo Lee

Lecturer in Chemical Biology, School of Chemistry, University of Southampton, UK
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2011 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
KBKeriann M Backus
Keriann M Backus
HBHelena I Boshoff
Helena I Boshoff
CBConor S Barry
Conor S Barry
OBOmar Boutureira
Omar Boutureira
MPMitul K Patel
Mitul K Patel
BDBenjamin G Davis
Benjamin G Davis

1 January 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ALAndrew L. Lovering
Andrew L. Lovering
SLSeung Seo Lee
Seung Seo Lee
YKYoung-Wan Kim
Young-Wan Kim
SWStephen G. Withers
Stephen G. Withers
NSNatalie C. J. Strynadka
Natalie C. J. Strynadka
We have determined the first structure of a family 31 α-glycosidase, that of YicI from Escherichia coli, both free and trapped as a 5-fluoroxylopyranosyl-enzyme intermediate via reaction with 5-fluoro-α-d-xylopyranosyl fluoride. Our 2.2-Å resolution structure shows an intimately associated hexamer with structural elements from several monomers converging at each of the six active sites. Our kinetic and mass spectrometry analyses verified several of the features observed in our structural data, including a covalent linkage from the carboxylate side chain of the identified nucleophile Asp416 to C-1 of the sugar ring. Structure-based sequence comparison of YicI with the mammalian α-glucosidases lysosomal α-glucosidase and sucrase-isomaltase predicts a high level of structural similarity and provides a foundation for understanding the various mutations of these enzymes that elicit human disease.

7 August 2011 in Nature Chemical Biology
Verified
Journal Article
Closed access
SLSeung Seo Lee
Seung Seo Lee
SHSung You Hong
Sung You Hong
JEJames C Errey
James C Errey
AIAtsushi Izumi
Atsushi Izumi
GDGideon J Davies
Gideon J Davies
BDBenjamin G Davis
Benjamin G Davis

1 October 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
YKYoung-Wan Kim
Young-Wan Kim
SLSeung Seo Lee
Seung Seo Lee
RWR. Antony J. Warren
R. Antony J. Warren
SWStephen G. Withers
Stephen G. Withers
The Agrobacterium sp. beta-glucosidase (Abg) is a retaining beta-glycosidase and its nucleophile mutants, termed Abg glycosynthases, catalyze the formation of glycosidic bonds using alpha-glycosyl fluorides as donor sugars and various aryl glycosides as acceptor sugars. Two rounds of random mutagenesis were performed on the best glycosynthase to date (AbgE358G), and transformants were screened using an on-plate endocellulase coupled assay. Two highly active mutants were obtained, 1D12 (A19T, E358G) and 2F6 (A19T, E358G, Q248R, M407V) in the first and second rounds, respectively. Relative catalytic efficiencies (kcat/Km) of 1:7:27 were determined for AbgE358G, 1D12, and 2F6, respectively, using alpha-D-galactopyranosyl fluoride and 4-nitrophenyl beta-D-glucopyranoside as substrates. The 2F6 mutant is not only more efficient but also has an expanded repertoire of acceptable substrates. Analysis of a homology model structure of 2F6 indicated that the A19T and M407V mutations do not interact directly with substrates but exert their effects by changing the conformation of the active site. Much of the improvement associated with the A19T mutation seems to be caused by favorable interactions with the equatorial C2-hydroxyl group of the substrate. The alteration of torsional angles of Glu-411, Trp-412, and Trp-404, which are components of the aglycone (+1) subsite, is an expected consequence of the A19T and M407V mutations based on the homology model structure of 2F6.

1 November 2018 in Cell
Verified
Journal Article
Open access
Yin Yao DongYin Yao Dong
Yin Yao Dong
HWHua Wang
Hua Wang
APAshley C.W. Pike
Ashley C.W. Pike
SCStephen A. Cochrane
Stephen A. Cochrane
SHSadra Hamedzadeh
Sadra Hamedzadeh
ECElisabeth P. Carpenter
Elisabeth P. Carpenter
Protein N-glycosylation is a widespread post-translational modification. The first committed step in this process is catalysed by dolichyl-phosphate N-acetylglucosamine-phosphotransferase DPAGT1 (GPT/E.C. 2.7.8.15). Missense DPAGT1 variants cause congenital myasthenic syndrome and disorders of glycosylation. In addition, naturally-occurring bactericidal nucleoside analogues such as tunicamycin are toxic to eukaryotes due to DPAGT1 inhibition, preventing their clinical use. Our structures of DPAGT1 with the substrate UDP-GlcNAc and tunicamycin reveal substrate binding modes, suggest a mechanism of catalysis, provide an understanding of how mutations modulate activity (thus causing disease) and allow design of non-toxic "lipid-altered" tunicamycins. The structure-tuned activity of these analogues against several bacterial targets allowed the design of potent antibiotics for Mycobacterium tuberculosis, enabling treatment in vitro, in cellulo and in vivo, providing a promising new class of antimicrobial drug.

20 May 2012 in Nature Chemistry
Verified
Journal Article
Closed access
FWFilip J. Wyszynski
Filip J. Wyszynski
SLSeung Seo Lee
Seung Seo Lee
TYTomoaki Yabe
Tomoaki Yabe
HWHua Wang
Hua Wang
JGJuan Pablo Gomez-Escribano
Juan Pablo Gomez-Escribano
BDBenjamin G. Davis
Benjamin G. Davis